MedTrace Logo

Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia

NCT01480687 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2011-11-29

No results posted yet for this study

Summary

The objective of this study is to compare the effects of ciprofibrate versus omega-3 fatty acid supplementation on the vascular structure and function in hypertensive patients with hypertriglyceridemia.

Conditions

Interventions

DIETARY_SUPPLEMENT

DHA-EPA

1800 mg/day

DRUG

Ciprofibrate

100 mg/day

Sponsors & Collaborators

  • Rio de Janeiro State Research Supporting Foundation (FAPERJ)

    collaborator OTHER_GOV

  • Hospital Universitario Pedro Ernesto

    lead OTHER

Principal Investigators

  • Marcela A Casanova, MSc · State University of Rio de Janeiro

  • Mario F Neves, MD, PhD · State University of Rio de Janeiro

  • Wille Oigman, MD, PhD · State University of Rio de Janeiro

  • Fernanda J Medeiros, PhD · Federal University of the State of Rio de Janeiro

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01480687 on ClinicalTrials.gov